The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $118.54, a high ...

Boston Scientific Corp. closed 12.60% below its 52-week high of $107.17, which the company achieved on February 5th.

Shares of Boston Scientific Corp. BSX shed 4.27% to $92.64 Thursday, on what proved to be an all-around dismal trading ...

We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX.

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...

According to Benzinga Pro, Boston Scientific's peer group average for short interest as a percentage of float is 4.50%, which means the company has less short interest than most of its peers. Did you ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific (BSX – Research Report).

Boston Scientific (BSX) closed the latest trading day at $93.67, indicating a +1.11% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 1.81%. At ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

In the latest trading session, Boston Scientific (BSX) closed at $93.67, marking a +1.11% move from the previous day. Boston Scientific (NYSE:BSX) experienced a 6% decline in stock price over the ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...